The absolute risk of atypical femoral fractures (AFF) with bisphosphonate use is very small and disappears after stopping therapy, a nationwide Danish analysis has confirmed. With uncertainty over the risk of atypical fractures still deterring use of bisphosphonates and also creating doubts about the need for ‘drug holidays’, US researchers investigated the absolute numbers of ...
Atypical femoral fractures are rare with bisphosphonate use, national study confirms
By Michael Woodhead
15 Sep 2020